Daniel R Gomez

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
  2. doi request reprint Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:1096-103. 2009
  3. doi request reprint Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 115:2128-37. 2009
  4. doi request reprint Radiotherapy after surgical resection for head and neck mucosal melanoma
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Am J Clin Oncol 33:281-5. 2010
  5. doi request reprint Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA
    J Thorac Oncol 8:238-45. 2013
  6. doi request reprint Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA
    Int J Radiat Oncol Biol Phys 86:665-70. 2013
  7. doi request reprint Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 81:e207-13. 2011
  8. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
  9. doi request reprint Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer
    Qingsong Pang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 85:1332-9. 2013
  10. pmc Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly
    Shervin M Shirvani
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 84:1060-70. 2012

Detail Information

Publications16

  1. ncbi request reprint Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 70:1365-72. 2008
    ..To analyze the recent experience of patients with adenoid cystic carcinoma treated with radiation therapy at Memorial Sloan-Kettering Cancer Center...
  2. doi request reprint Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 73:1096-103. 2009
    ..To present our single-institution experience of intensity-modulated radiotherapy (IMRT) for oral cavity cancer...
  3. doi request reprint Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer 115:2128-37. 2009
    ..The aim of the current study was to determine patterns of failure and adverse prognostic features...
  4. doi request reprint Radiotherapy after surgical resection for head and neck mucosal melanoma
    Abraham J Wu
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    Am J Clin Oncol 33:281-5. 2010
    ..To present our single-institution experience with postoperative radiotherapy for mucosal melanoma of the head and neck...
  5. doi request reprint Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA
    J Thorac Oncol 8:238-45. 2013
    ....
  6. doi request reprint Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA
    Int J Radiat Oncol Biol Phys 86:665-70. 2013
    ..Hypofractionated radiation regimens, if tolerable, may provide an option to these patients for effective local control...
  7. doi request reprint Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 81:e207-13. 2011
    ..However, the incidence of this complication with intensity-modulated radiation therapy (IMRT) and dental sequelae with this technique have not been fully elucidated...
  8. doi request reprint Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities
    Bradford S Hoppe
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Radiat Oncol Biol Phys 72:763-9. 2008
    ..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
  9. doi request reprint Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer
    Qingsong Pang
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 85:1332-9. 2013
    ..We investigated potential associations between single nucleotide polymorphisms (SNPs) in HSPB1 and risk of RP after chemoradiation for non-small cell lung cancer (NSCLC)...
  10. pmc Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly
    Shervin M Shirvani
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 84:1060-70. 2012
    ....
  11. doi request reprint Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer
    Jose L Lopez Guerra
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 83:e537-43. 2012
    ....
  12. doi request reprint Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Radiat Oncol Biol Phys 86:529-33. 2013
    ....
  13. doi request reprint Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
    Cancer 119:1428-36. 2013
    ..For this population-based study, the authors assessed the rates of antiemetic prophylaxis use, and predictors of such use, among patients who were receiving platinum-based chemotherapy for lung cancer between 2001 and 2007...
  14. pmc Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy
    Daniel R Gomez
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiother Oncol 93:414-8. 2009
    ..There has been an increase in the utilization of single-fraction stereotactic body radiation therapy (SBRT) to treat thoracic structures, but there have been few reports describing toxicity outcomes with this treatment...
  15. pmc A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors
    Daniel R Gomez
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Cancer 118:444-51. 2012
    ..The optimal treatment for locally advanced superior sulcus tumors is not clear. The authors report long-term results of a trial examining the safety and efficacy of surgery followed by concurrent chemoradiation therapy for this disease...
  16. pmc High failure rate in spinal ependymomas with long-term follow-up
    Daniel R Gomez
    Department of Radiation Oncology, University of California, San Francisco, CA 94143, USA
    Neuro Oncol 7:254-9. 2005
    ..The overall high rate of recurrence leads us to recommend radiation to doses of 45 to 54 Gy for all patients who do not have gross total resections, and long, close follow-up...